Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000725424 | SCV000336850 | uncertain significance | not provided | 2017-11-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001081883 | SCV000650462 | likely benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000725424 | SCV000715958 | likely benign | not provided | 2019-12-27 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000725424 | SCV001155510 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | PLEC: BP4, BP7 |
Prevention |
RCV003909959 | SCV004722875 | likely benign | PLEC-related condition | 2023-11-14 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Diagnostic Genome Analysis, |
RCV000725424 | SCV001799921 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000725424 | SCV001963967 | uncertain significance | not provided | no assertion criteria provided | clinical testing |